100 ML midazolam 1 MG/ML Injection — RxCUI 2541171
RxNorm drug concept · Semantic clinical drug
RxCUI 2541171
Semantic clinical drug · SCD
● Current RxNorm concept 10 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2541171
Official name100 ML midazolam 1 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmidazolam 100 MG per 100 ML Injection; midazolam 100 MG in 100 mL Injection
FDA products mapped10
Package NDCs mapped12
Reported Medicaid activity (SDUD)38 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Midazolam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That's actually one of the intentional effects of midazolam — it reliably blocks the brain's ability to form new memories for several hours after a dose. So even if you're awake an...
- Why will I not remember what happened during my procedure?
- You should not drive or operate any machinery until the full effects have worn off — and that can take up to 6 hours or sometimes longer. Plan to have someone drive you home. Even...
- Is it safe to go home right after receiving midazolam?
🕸️ Concept Web — How 100 ML midazolam 1 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
100 ML midazolam 1 MG/ML Injection
RxCUI 2541171 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Midazolam
6960IN
-
Midazolam
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Midazolam Injection
1666797SCDF -
Midazolam Injectable Product
1164715SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Midazolam Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Midazolam 1 MG/ML
328485SCDC
-
Midazolam 1 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Midazolam 1 MG/ML
SCDC · 328485 -
Midazolam Injection
SCDF · 1666797 -
Midazolam Injectable Product
SCDG · 1164715
📦 FDA Products & Package NDCs
10 products · 12 package NDCs
12 package NDCs map to RxCUI 2541171 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9379-10 | 10 POUCH in 1 CARTON (0143-9379-10) / 1 BAG in 1 POUCH (014... | Midazolam in Sodium Chloride | Hikma Pharmaceuticals USA Inc. | 2023-05-19 |
| 00143-9380-10 | 10 POUCH in 1 CARTON (0143-9380-10) / 1 BAG in 1 POUCH (014... | Midazolam in Sodium Chloride | Hikma Pharmaceuticals USA Inc. | 2023-05-19 |
| 00264-8002-32 | 30 CONTAINER in 1 CASE (0264-8002-32) / 100 mL in 1 CONTAIN... | MIDAZOLAM IN 0.8% SODIUM CHLORIDE | B. Braun Medical Inc. | 2025-10-15 |
| 00264-8005-31 | 40 CONTAINER in 1 CASE (0264-8005-31) / 50 mL in 1 CONTAINE... | MIDAZOLAM IN 0.8% SODIUM CHLORIDE | B. Braun Medical Inc. | 2025-10-15 |
| 25021-0688-82 | 10 BAG in 1 CARTON (25021-688-82) / 50 mL in 1 BAG | Midazolam in Sodium Chloride | Sagent Pharmaceuticals | 2025-04-15 |
| 25021-0688-87 | 20 BAG in 1 CARTON (25021-688-87) / 100 mL in 1 BAG | Midazolam in Sodium Chloride | Sagent Pharmaceuticals | 2025-04-15 |
| 44567-0610-10 | 10 BAG in 1 CARTON (44567-610-10) / 50 mL in 1 BAG (44567-6... | Midazolam in Sodium Chloride | WG Critical Care, LLC. | 2021-04-19 |
| 44567-0611-10 | 10 BAG in 1 CARTON (44567-611-10) / 100 mL in 1 BAG (44567-... | Midazolam in Sodium Chloride | WG Critical Care, LLC. | 2021-04-19 |
| 65219-0650-10 | 10 POUCH in 1 CARTON (65219-650-10) / 1 BAG in 1 POUCH / 10... | Midazolam In Sodium Chloride | FRESENIUS KABI USA, LLC | 2025-01-15 |
| 65219-0650-50 | 10 POUCH in 1 CARTON (65219-650-50) / 1 BAG in 1 POUCH / 50... | Midazolam In Sodium Chloride | FRESENIUS KABI USA, LLC | 2025-01-15 |
| 68083-0618-10 | 10 POUCH in 1 CARTON (68083-618-10) / 1 BAG in 1 POUCH / 50... | Midazolam In Sodium Chloride | Gland Pharma Limited | 2024-08-12 |
| 68083-0619-10 | 10 POUCH in 1 CARTON (68083-619-10) / 1 BAG in 1 POUCH / 10... | Midazolam In Sodium Chloride | Gland Pharma Limited | 2024-08-12 |
Observed labelers:
B. Braun Medical Inc. (2) ·
FRESENIUS KABI USA, LLC (2) ·
Gland Pharma Limited (2) ·
Hikma Pharmaceuticals USA Inc. (2) ·
Sagent Pharmaceuticals (2) ·
WG Critical Care, LLC. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2251 | Inj midazolam in 0.9% nacl | 8 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.